Dr. Robert P. Dunne — Melbourne, Florida

Dr. Robert P. Dunne is a clinical research site located in Melbourne, Florida, United States 32935.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Dr. Robert P. Dunne has participated in 1 clinical trials.

Therapeutic areas: Onychomycosis.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Melbourne

Browse all research sites in Florida · View every site in Melbourne

• Melbourne Internal Medicine Associates / Century Research Associates, Holmes Regional Medical Center Hospital
• University Clinical Research-DeLand, LLC dba Accel Research Sites
• Florida Eye Associates
• Optimal Research
• GSK Investigational Site
• Health First Holmes Regional Medical Center
• Pfizer Investigational Site
• Research Site
• Holmes Regional Medical Center
• Novo Nordisk Investigational Site
• Melbourne Internal Medicine Associates
• Accelovance

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dr. Robert P. Dunne?

Dr. Robert P. Dunne has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dr. Robert P. Dunne conducted?

Dr. Robert P. Dunne has 1 clinical trials on record. Their work covers Onychomycosis.

Is Dr. Robert P. Dunne accredited by Crixeo Clinical Trials?

Dr. Robert P. Dunne has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dr. Robert P. Dunne?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.